Global Central Nervous System Stimulant Drugs Market

1. Summary

The Global Central Nervous System Stimulant Drugs Market was valued at $9.8 bn. in 2025. During the forecast period 2025-2030, it is expected to grow at 6.4% CAGR, to an estimated market size of $13.4 bn. in 2030. A detailed breakdown by segment and geography is provided in the downloadable datasheet.

2. Market Definition

The global Central Nervous System (CNS) stimulant drugs market comprises pharmaceutical substances, primarily amphetamines and methylphenidate, designed to increase neurotransmitter activity to treat neurological and behavioral disorders. The scope includes medications for Attention-Deficit Hyperactivity Disorder (ADHD), narcolepsy, and sleep-wake dysregulation, while excluding non-stimulant psychiatric medications and broad-spectrum neurotherapeutics for neurodegenerative diseases.

3. Trends & Demand Drivers

Several key trends are expected to significantly impact the Central Nervous System Stimulant Drugs Market in the period 2025-30:

• The rising global prevalence and diagnosis rates of ADHD in both pediatric and adult populations are the primary drivers of market volume.
• There is a significant shift toward extended-release (ER) and long-acting formulations to improve patient compliance and provide smoother therapeutic effects.
• The expansion of telehealth and digital health platforms is facilitating easier access to diagnosis and remote prescription management for stimulant medications.
• Pharmaceutical R&D is increasingly focused on developing abuse-deterrent formulations and prodrugs to mitigate risks of diversion and addiction.
• Growing demand for adult neuro-performance and cognitive optimization is driving off-label usage and the exploration of new therapeutic indications.
• The integration of Artificial Intelligence (AI) in drug discovery is accelerating the identification of novel molecular targets and reducing clinical trial attrition.
• Increasing mental health awareness and the reduction of social stigma are encouraging higher treatment-seeking behavior in emerging economies.

4. Market Breakdown

The downloadable datasheet breaks market sizes and growth rates (CAGRs) down into the following geographies and segments: